key: cord-0699957-7le04zd9
authors: Mungmunpuntipantip, Rujittika; Wiwanitkit, Viroj
title: Acute cellular rejection in liver transplantation recipients following coronavirus disease 2019 vaccination
date: 2022-04-16
journal: Liver Transpl
DOI: 10.1002/lt.26459
sha: a0c5d95ea11c3c23f9c94bcc967560b45c7fe08d
doc_id: 699957
cord_uid: 7le04zd9

nan

To the editor, We would like to share ideas on the publication "Acute cellular rejection (ACR) in liver transplantation (LT) recipients following vaccination against coronavirus disease 2019: A case series." [1] Sarwar et al. [1] noted that "we report a series of LT recipients who developed ACR following their COVID-19 vaccinations. Our findings highlight the need for comprehensive postvaccination surveillance programs in patients where the high immunogenicity of the vaccines could potentially provoke adverse events. It is important to note that all episodes of ACR in our series were easily treated without any serious complications, and our preliminary findings should not be used to discourage vaccination for COVID-19 in LT recipients." We agree that coronavirus disease 2019 (COVID-19) vaccination might cause a liver adverse effect. In the present report, vaccine recipients might have ACR but it might or might not be associated with COVID-19 vaccination. The possibility of a concurrent medical problem that might lead to ACR should be discussed. For example, a vaccine recipient might acquire concurrent dengue infection. [2] The acquired arbovirus disease in LT case is a rare clinical entity and usually underdiagnosed. [3] This clinical problem might be a cause of ACR. [4] 

Acute cellular rejection in liver transplantation recipients following vaccination against coronavirus disease 2019: a case series

Dengue after COVID-19 vaccination: possible and might be missed

A scoping review of transmission of dengue virus from donors to recipients after solid organ transplantation

Dengue virus infection in solid organ transplant recipients: a case series and literature review